Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Takeda Pharmaceutical (TAK) has a market cap of $45.76 billion USD. According to our data, Takeda Pharmaceutical is ranked No.427 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $45.76 B |
9.02%
|
| Dec 31, 2024 | $41.98 B |
-7.22%
|
| Dec 29, 2023 | $45.24 B |
-8.53%
|
| Dec 30, 2022 | $49.46 B |
14.45%
|
| Dec 31, 2021 | $43.21 B |
-25.11%
|
| Dec 31, 2020 | $57.70 B |
-7.75%
|
| Dec 31, 2019 | $62.55 B |
17.30%
|
| Dec 31, 2018 | $53.33 B |
-40.88%
|
| Dec 29, 2017 | $90.20 B |
36.91%
|
| Dec 30, 2016 | $65.88 B |
-16.98%
|
| Dec 31, 2015 | $79.35 B |
20.68%
|
| Dec 31, 2014 | $65.75 B |
-9.90%
|
| Dec 31, 2013 | $72.98 B |
3.69%
|
| Dec 31, 2012 | $70.38 B |
0.68%
|
| Dec 30, 2011 | $69.91 B |
-9.45%
|
| Dec 31, 2010 | $77.20 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
| Market Cap | = | TAK Stock Price | * | TAK Shares Outstanding |
| = | $14.54 | * | 3.15 B | |
| = | $45.76 B |